Skip to main content
AMGN
NASDAQ Life Sciences

Amgen Posts $6.45 Adjusted EPS for Third Quarter

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$460.57
Mkt Cap
$249.372B
52W Low
$292.12
52W High
$475.645
52W Position info
58% above low
Off High info
3.2% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

AMGN sits 58% above its 52-week low of $292.12.

Summary

Amgen reported third-quarter adjusted EPS of $7.08, replacing the earlier $6.45 figure. The company guided full-year adjusted EPS to $22.90-$23.70 and full-year EPS to $18.34-$19.28. The print lands after a strong Q2 in August, when revenue of $10.1B beat estimates and full-year sales guidance was raised to $38.2-39.4B. Shares sit near the 52-week high of $475.645, so the bar for this quarter is elevated. The overhangs remain the FDA's proposal to withdraw Tavneos and the unresolved $10.7B IRS tax dispute. Full release details, including revenue and any further guidance revision, will determine whether this EPS line holds up.

At the time of this announcement, AMGN was trading at $460.57 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $249.4B. The 52-week trading range was $292.12 to $475.65. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

AMGN - Latest Insights

AMGN
Nov 05, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $477.40
Real-time Price: $448.26 info
Change: -$29.14 (-6%) info
Market Cap: $242.469B info
AMGN
Nov 03, 2026, 6:37 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $464.92
Real-time Price: $448.26 info
Change: -$16.66 (-4%) info
Market Cap: $242.469B info
AMGN
Nov 03, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $463.00
Real-time Price: $448.26 info
Change: -$14.74 (-3%) info
Market Cap: $242.469B info
AMGN
Oct 26, 2026, 9:23 AM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $448.79
Real-time Price: $448.26 info
Change: -$0.5344 (-0.12%) info
Market Cap: $242.469B info
AMGN
Oct 24, 2026, 10:30 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $439.26
Real-time Price: $448.26 info
Change: +$9.00 (+2%) info
Market Cap: $242.469B info